MedTrace Logo

Kinetic Control Exercises to Reduce Pain and Improve Balance, Walking, and Stamina in Sacroiliac Joint Issues

NCT07229287 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-04-28

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effectiveness of the Kinetic control on pain, endurance, Gait and postural stability in patients suffering from chronic sacroiliac joint dysfunction.

The main question it aims to answer is:

* Does kinetic control training work on pain in SIJ dysfunction?
* Does kinetic control therapy work on functional outcomes, including gait metrics, postural sway, and lumbar endurance?

The treatment arm will receive the Kinetic control training, and the comparison arm will undergo standard physical therapy care. Participants will be asked to perform movement control exercises based on the principle of kinetic control training core muscles and hip muscles after routine physical therapy. The participants in the control/comparison group will only receive routine physical therapy that includes a heating pad, TENS, joint mobilizations, and stretching and strengthening exercises.

Conditions

  • Sacroiliac Joint Dysfunction

Interventions

OTHER

movement retraining/ kinetic control

this intervention is for experimental group. Kinetic control is grounded in the principles of motor control training and movement retraining. In this study, this intervention primarily focuses on activating and strengthening two key muscle groups: the abdominals and obliques, along with the gluteal muscles.

OTHER

Routine Physical therapy

Routine physical therapy intervention will be given to the patient which includes, hot pack for 15 mins and exercise therapy for 25 mins, involving floor sessions including sacroiliac joint self-mobilization, piriformis, gluteus medius, minimums, and maximus stretches, leg pressing inward/outward, knee-to-shoulder stretch, quadriceps and hamstring stretches, standard and one-leg elevated

Sponsors & Collaborators

  • Lahore University of Biological and Applied Sciences

    lead OTHER

Principal Investigators

  • Manum Tahir · Lahore University of Biological and Applied Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-17
Primary Completion
2026-02-20
Completion
2026-02-28

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07229287 on ClinicalTrials.gov